TickerFacts.

Immucell Corp (ICCC): Total Assets

Annual figures by period end, from SEC filings.

$42.53M
As of 2025-12-31
$46.63M
As of 2026-06-30
-1.8%
3-year compound annual growth
+1.1%
5-year compound annual growth
+11.3%
10-year compound annual growth
$45.10M2010-12-31: $10.75M2011-12-31: $10.99M2012-12-31: $11.03M2013-12-31: $10.96M2014-12-31: $11.05M2015-12-31: $14.54M2016-12-31: $24.70M2017-12-31: $34.30M2018-12-31: $32.73M2019-12-31: $38.69M2020-12-31: $40.35M2021-12-31: $44.47M2022-12-31: $44.86M2023-12-31: $43.81M2024-12-31: $45.10M2025-12-31: $42.53M$42.53M
2010-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$42.53M-5.7%2026-03-30, Balance as of period end
2024-12-31$45.10M+3.0%2026-03-30, Balance as of period end
2023-12-31$43.81M-2.3%2025-03-28, Balance as of period end
2022-12-31$44.86M+0.9%2024-04-01, Balance as of period end
2021-12-31$44.47M+10.2%2023-03-29, Balance as of period end
2020-12-31$40.35M+4.3%2022-03-30, Balance as of period end
2019-12-31$38.69M+18.2%2021-03-30, Balance as of period end
2018-12-31$32.73M-4.6%2020-03-27, Balance as of period end
2017-12-31$34.30M+38.9%2019-03-22, Balance as of period end
2016-12-31$24.70M+69.9%2018-03-29, Balance as of period end
2015-12-31$14.54M+31.6%2017-03-30, Balance as of period end
2014-12-31$11.05M+0.8%2016-03-25, Balance as of period end
2013-12-31$10.96M-0.6%2015-03-26, Balance as of period end
2012-12-31$11.03M+0.4%2014-03-26, Balance as of period end
2011-12-31$10.99M+2.2%2013-03-28, Balance as of period end
2010-12-31$10.75Mn/a2012-03-27, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Immucell Corp (ICCC)2025-12-31$42.53M-5.7%
Alpha Teknova, Inc. (TKNO)2025-12-31$103.58M-12.8%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$842.13M-29.3%
Aspira Women's Health Inc. (AWHL)2025-12-31$5.46M-0.6%
Anbio Biotechnology (NNNN)2025-12-31$30.24M+59.8%
Biomerica Inc (BMRA)2026-05-31$6.76M+13.7%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$25.76M-26.6%
Volitionrx Ltd (VNRX)2025-12-31$6.90M-26.6%
Celldex Therapeutics, Inc. (CLDX)2025-12-31$582.98M-26.4%

Compare ICCC, TKNO, NTLA, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗